References

1. Thakker, D., Raval, A., Patel, I., & Walia, R. (2015). N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstetrics and Gynecology International, 2015, 817849.

2. Asefi, M., & Asefi, M. (2024). Efficacy of N-Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. Nutrients, 17(2), 284.

3. Yang, R., Li, H., Wu, Y., Shan, J., & Zhao, J. (2022). N-Acetylcysteine improves oocyte quality through modulating the Nrf2 signaling pathway to ameliorate oxidative stress caused by repeated controlled ovarian hyperstimulation. Reproduction, Fertility and Development, 34(12), 779-790.

4. Showell, M. G., Brown, J., Clarke, J., & Hart, R. J. (2011). Antioxidants for female subfertility. Cochrane Database of Systematic Reviews, (11), CD007807.

5. Tenório, M. C. D. S., Graciliano, N. G., Moura, F. A., Oliveira, A. C. M. D., & Goulart, M. O. F. (2021). N-Acetylcysteine (NAC): Impacts on Human Health. Antioxidants, 10(6), 967.

6. Kilic-Okman, T., Kucuk, M., & Altaner, S. (2005). The effect of N-acetyl-cysteine on the homocysteine and lipid-lipoprotein levels in patients with polycystic ovary syndrome. Fertility and Sterility, 84, S311.

7. Sambu, S., & Suneetha, S. (2021). N-acetylcysteine a drug with wide spectrum of uses. IOSR Journal of Dental and Medical Sciences, 20(8), 41-45.

8. Fulghesu, A. M., Ciampelli, M., Muzj, G., Belosi, C., Selvaggi, L., & Lanzone, A. (2002). N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertility and Sterility, 77(6), 1128-1135.

9. U.S. Food and Drug Administration. (2022). NAC in conventional food and dietary supplements.

10. Pei, Y., Liu, H., & Yang, Y. (2018). The protective role of N-acetylcysteine in diabetic nephropathy. BioMed Research International, 2018, 9217854.

11. Salehpour, S., Shidfar, F., Hedayati, M., & Tehrani, F. R. (2019). N-acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology Research, 45(4), 859-865.

12. Divyesh, T., Amol, R., & Ishita, P. (2015). N-acetylcysteine for polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled clinical trials. Obstetrics and Gynecology International, 2015.

13. Zhitkovich, A. (2019). N-Acetylcysteine: A drug that is looking for a disease. Journal of Cellular Biochemistry, 120(11), 18451-18452.

14. Adeoye, O., Olawumi, J., Opeyemi, A., & Christiania, O. (2018). Review on the role of glutathione on oxidative stress and infertility. Journal of BRA-Medical Research, 1(4).

15. Ates, M., & Guresci, S. (2023). The effect of N-acetylcysteine on the success of intrauterine insemination in patients with polycystic ovary syndrome. Journal of Obstetrics and Gynaecology, 43(1), 2176469.

16. Agarwal, A., Aponte-Mellado, A., Premkumar, B. J., Shaman, A., & Gupta, S. (2012). The effects of oxidative stress on female reproduction: a review. Reproductive Biology and Endocrinology, 10(1), 1-31.

17. Rushworth, G. F., & Megson, I. L. (2014). Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Pharmacology & Therapeutics, 141(2), 150-159.

18. Sacchinelli, A., Venturella, R., Lico, D., Di Cello, A., Lucia, A., & Zullo, F. (2014). The efficacy of inositol and N-acetyl cysteine administration (Ovaric HP) in patients with polycystic ovary syndrome: a pilot study. Journal of Ovarian Research, 7(1), 1-5.

19. Anastasi, E., Scaramuzzino, S., Viscardi, M. F., Viggiani, V., Piccioni, M. G., & Porpora, M. G. (2023). Efficacy of N-Acetylcysteine on Endometriosis-Related Pain, Size Reduction of Ovarian Endometriomas, and Fertility Outcomes. International Journal of Environmental Research and Public Health, 20(6), 4686.

20. Sadowska, A. M. (2012). N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease, 6(3), 127-135.

21. Nas, F. S., & Ali, A. (2017). The effect of N-acetylcysteine on cervical mucus and pregnancy rate in clomiphene citrate-resistant polycystic ovary syndrome. Journal of Obstetrics and Gynaecology, 37(4), 481-484.

22. Asefi, M., & Asefi, M. (2025). Efficacy of N-Acetylcysteine in Polycystic Ovary Syndrome: Systematic Review and Meta-Analysis. Nutrients, 17(2), 284. (pre-print)

23. Javanmanesh, F., Kashanian, M., Rahimi, M., & Sheikhansari, N. (2016). A comparison between the effects of metformin and N-acetyl cysteine (NAC) on some metabolic and endocrine biomarkers in women with polycystic ovary syndrome. Journal of Reproduction & Infertility, 17(1), 21.

24. Cheraghi, E., Mehranjani, M. S., Shariatzadeh, M. A., Esfahani, M. H. N., & Ebrahimi, Z. (2016). N-Acetylcysteine improves oocyte and embryo quality in polycystic ovary syndrome patients undergoing intracytoplasmic sperm injection: an alternative to metformin. Reproduction, Fertility and Development, 28(6), 723-731.

25. Oner, G., & Muderris, I. I. (2013). Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology, 168(2), 221-224.

26. Zhang, T., Li, Z., Ren, X., Li, Y., & Zhang, J. (2023). Effects of N-acetylcysteine on women with polycystic ovary syndrome: A systematic review and meta-analysis. Journal of Obstetrics and Gynaecology Research, 49(3), 819-829.

27. Elnashar, A., Fahmy, M., Mansour, A., & Ibrahim, K. (2007). N-acetyl cysteine vs. metformin in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective randomized controlled study. Fertility and Sterility, 88, S22.

28. Mishima, T., & Taketani, Y. (2017). The effect of N-acetylcysteine on ovulation and pregnancy in patients with polycystic ovary syndrome. Journal of Clinical Medicine, 6(8), 76.

29. El-Khayat, W., El-Ghamry, N., & El-Genedy, A. (2024). N-acetylcysteine as an adjuvant to letrozole for induction of ovulation in patients with polycystic ovary syndrome. International Journal of Gynecology & Obstetrics, 164(1), 221-226.

30. ClinicalTrials.gov. (2009). N-acetylcysteine Versus Metformin in Clomiphene Citrate-resistant Polycystic Ovary Syndrome. NCT01008046.

31. ClinicalTrials.gov. (2016). N-acetylcysteine as an Adjuvant to Letrozole in Clomiphene-resistant PCOS. NCT02775734.

32. Badawy, A., & El-Ghazaly, M. (2009). N-acetyl cysteine versus metformin in clomiphene citrate resistant polycystic ovary syndrome: a prospective randomized controlled trial. Fertility and Sterility, 92(3), S135.

33. Pittaluga, E., & Sesti, F. (2021). The role of N-acetylcysteine in the management of endometriosis. Current Opinion in Obstetrics and Gynecology, 33(4), 295-300.

34. Porpora, M. G., Brunelli, R., Costa, G., Imperiale, L., Krasnowska, E. K., Lundeberg, T., ... & Parasassi, T. (2013). A promise in the treatment of endometriosis: an observational cohort study on ovarian endometrioma reduction by N-acetylcysteine. Evidence-Based Complementary and Alternative Medicine, 2013.

35. Amin, A. F., Shaaban, O. M., & Bediawy, M. A. (2008). N-acetyl cysteine for treatment of recurrent unexplained pregnancy loss. Reproductive BioMedicine Online, 17(6), 803-806.

36. Smits, R. M., Mackenzie-Proctor, R., Yazdani, A., Stankiewicz, M. T., Jordan, V., & Showell, M. G. (2023). Antioxidants for female subfertility. Cochrane Database of Systematic Reviews, (11).

37. Al-Mola, H. F. (2019). Effect of N-acetylcysteine on the outcome of in vitro fertilization/intracytoplasmic sperm injection cycle in patients with advanced maternal age. Middle East Fertility Society Journal, 24(1), 1-5.

38. Whitaker, B. D., & Knight, J. W. (2011). The effects of n-acetyl-l-cysteine supplementation on in vitro porcine oocyte maturation and subsequent fertilisation and embryonic development. Reproduction, Fertility and Development, 24(1), 133-133.

39. Cheraghi, E., Soleimani, M., & Nasr Esfahani, M. H. (2013). Association of follicular fluid endocrine changes with oocyte morphology and quality in PCOS patients undergoing metformin and N-acetylcysteine treatment. International Journal of Fertility & Sterility, 7(Suppl 1), 44.

40. Sandilands, E. A., & Bateman, D. N. (2009). Adverse reactions associated with acetylcysteine. Clinical Toxicology, 47(2), 81-88.

41. Millea, P. J. (2009). N-acetylcysteine: multiple clinical applications. American Family Physician, 80(3), 265-269.

42. Tenório, M., Macedo, C., de Lira, C. A. C., & de Oliveira, A. C. M. (2021). N-acetylcysteine (NAC) as a pharmacological agent for the treatment of COVID-19. Brazilian Journal of Pharmaceutical Sciences, 57.

43. U.S. Food and Drug Administration. (2004). Pharmacology Review: Acetadote (acetylcysteine) Injection. NDA 21-539.